Literature DB >> 17561510

Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation.

Lise Bjørkhaug1, Janne Molnes, Oddmund Søvik, Pål Rasmus Njølstad, Torgeir Flatmark.   

Abstract

Human glucokinase (hGK) is a monomeric enzyme highly regulated in pancreatic beta-cells (isoform 1) and hepatocytes (isoforms 2 and 3). Although certain cellular proteins are known to either stimulate or inhibit its activity, little is known about post-translational modifications of this enzyme and their possible regulatory functions. In this study, we have identified isoforms 1 and 2 of hGK as novel substrates for the ubiquitin-conjugating enzyme system of the rabbit reticulocyte lysate. Both isoforms were polyubiquitinated on at least two lysine residues, and mutation analysis indicated that multiple lysine residues functioned as redundant acceptor sites. Deletion of its C-terminal alpha-helix, as part of a ubiquitin-interacting motif, affected the polyubiquitination at one of the sites and resulted in a completely inactive enzyme. Evidence is presented that poly/multiubiquitination of hGK in vitro serves as a signal for proteasomal degradation of the newly synthesized protein. Moreover, the recombinant hGK was found to interact with and to be allosterically activated up to approximately 1.4-fold by purified free pentaubiquitin chains at approximately 100 nm (with an apparent EC(50) of 93 nm), and possibly also by unidentified polyubiquitinated proteins assigned to their equilibrium binding to the ubiquitin-interacting motif site. The affinity of pentaubiquitin binding to hGK is regulated by the ligand (d-glucose)-dependent conformational state of the site. Both ubiquitination of hGK and its activation by polyubiquitin chains potentially represent physiological regulatory mechanisms for glucokinase-dependent insulin secretion in pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561510     DOI: 10.1074/jbc.M700517200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels.

Authors:  Michele L Markwardt; Andongfac Nkobena; Shi-Ying Ding; Mark A Rizzo
Journal:  Mol Endocrinol       Date:  2012-07-06

2.  GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation.

Authors:  Maria Negahdar; Ingvild Aukrust; Bente B Johansson; Janne Molnes; Anders Molven; Franz M Matschinsky; Oddmund Søvik; Rohit N Kulkarni; Torgeir Flatmark; Pål Rasmus Njølstad; Lise Bjørkhaug
Journal:  Biochim Biophys Acta       Date:  2012-07-20

3.  SUMOylation of pancreatic glucokinase regulates its cellular stability and activity.

Authors:  Ingvild Aukrust; Lise Bjørkhaug; Maria Negahdar; Janne Molnes; Bente B Johansson; Yvonne Müller; Wilhelm Haas; Steven P Gygi; Oddmund Søvik; Torgeir Flatmark; Rohit N Kulkarni; Pål R Njølstad
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

4.  The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents.

Authors:  Julien Rousseaux; Alain Duhamel; Julie Dumont; Jean Dallongeville; Denes Molnar; Kurt Widhalm; Yannis Manios; Michael Sjöström; Anthony Kafatos; Christina Breidenassel; Marcela Gonzales-Gross; Magdalena Cuenca-Garcia; Laura Censi; Marcos Ascensión; Stefaan De Henauw; Luis A Moreno; Aline Meirhaeghe; Frédéric Gottrand
Journal:  J Lipid Res       Date:  2015-07-01       Impact factor: 5.922

5.  Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.

Authors:  Nicola L Beer; Martijn van de Bunt; Kevin Colclough; Christine Lukacs; Paul Arundel; Constance L Chik; Joseph Grimsby; Sian Ellard; Anna L Gloyn
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

Review 6.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

Review 7.  Assessing the potential of glucokinase activators in diabetes therapy.

Authors:  Franz M Matschinsky
Journal:  Nat Rev Drug Discov       Date:  2009-04-17       Impact factor: 84.694

8.  Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.

Authors:  Jung Min Choi; Moon-Hyeong Seo; Hyun-Ho Kyeong; Eunkyung Kim; Hak-Sung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

9.  Identification of the ubiquitin-like domain of midnolin as a new glucokinase interaction partner.

Authors:  Anke Hofmeister-Brix; Katrin Kollmann; Sara Langer; Julia Schultz; Sigurd Lenzen; Simone Baltrusch
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

Review 10.  Molecular physiology of mammalian glucokinase.

Authors:  P B Iynedjian
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.